Online first
Original article
Published online: 2024-07-08
Is the KOS-Zawał coordinated care program effective in reducing long-term cardiovascular risk in coronary artery disease patients in Poland? Insights from analysis of statin persistence in a nationwide cohort
Pubmed: 38988238
Abstract
Not available
References
- Główny Urząd Statystyczny. Zgony według przyczyn za I półrocze 2020 roku - dane wstępne. [Deaths by causes for the first half of 2020 - preliminary data.]. https://stat.gov.pl/obszary-tematyczne/ludnosc/statystyka-przyczyn-zgonow/zgony-wedlug-przyczyn-za-i-polrocze-2020-roku-dane-wstepne,9,1.html.
- Jozwiak J, Studzinski K, Tomasik T, et al. The prevalence of cardiovascular risk factors and cardiovascular disease among primary care patients in Poland: results from the LIPIDOGRAM2015 study. European Heart Journal. 2020; 41(Supplement_2).
- Pająk A, Szafraniec K, Polak M, et al. WOBASZ Investigators. Changes in the prevalence, treatment, and control of hypercholesterolemia and other dyslipidemias over 10 years in Poland: the WOBASZ study. Pol Arch Med Wewn. 2016; 126(9): 642–652.
- Zdrojewski T, Solnica B, Cybulska B, et al. Prevalence of lipid abnormalities in Poland. The NATPOL 2011 survey. Kardiol Pol. 2016; 74(3): 213–223.
- Szymański FM, Mickiewicz A, Dzida G, et al. Management of dyslipidemia in Poland: Interdisciplinary Expert Position Statement endorsed by the Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy. The Fourth Declaration of Sopot. Cardiol J. 2022; 29(1): 1–26.
- Oesterle A, Liao JK. The Pleiotropic Effects of Statins - From Coronary Artery Disease and Stroke to Atrial Fibrillation and Ventricular Tachyarrhythmia. Curr Vasc Pharmacol. 2019; 17(3): 222–232.
- Kozela M, Szafraniec K, Broda G, et al. POLKARD Study Group. Detection and treatment of hypercholesterolemia in primary health care. Results of the POLKARD program of the Ministry of Health of the Republic of Poland. Pol Arch Med Wewn. 2012; 122(4): 154–161.
- Sliż D, Filipiak KJ, Naruszewicz M, et al. Standards of statin usage in Poland in high-risk patients: 3ST-POL study results. Kardiol Pol. 2013; 71(3): 253–259.
- Vrijens B, De Geest S, Hughes DA, et al. ABC Project Team. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012; 73(5): 691–705.
- Kardas P, Kwiatek A, Włodarczyk P, et al. Statins use amidst the pandemic: prescribing, dispensing, adherence, persistence, and correlation with COVID-19 statistics in nationwide real-world data from Poland. Front Pharmacol. 2024; 15: 1350717.
- Shalev V, Goldshtein I, Halpern Y, et al. Association between persistence with statin therapy and reduction in low-density lipoprotein cholesterol level: analysis of real-life data from community settings. Pharmacotherapy. 2014; 34(1): 1–8.
- Bansilal S, Castellano JM, Garrido E, et al. Assessing the Impact of Medication Adherence on Long-Term Cardiovascular Outcomes. J Am Coll Cardiol. 2016; 68(8): 789–801.
- World Health Organization. (2003). Adherence to long-term therapies: evidence for action. https://apps.who.int/iris/handle/10665/42682 (02.01.2023).
- Kardas P. From non-adherence to adherence: Can innovative solutions resolve a longstanding problem? Eur J Intern Med. 2024; 119: 6–12.
- Wojtyniak B, Gierlotka M, Opolski G, et al. Observed and relative survival and 5-year outcomes of patients discharged after acute myocardial infarction: the nationwide AMI-PL database. Kardiol Pol. 2020; 78(10): 990–998.
- Sagan A, Rogala M, Buszman PP, et al. Improved coordination of care after acute myocardial infarction in Poland since 2017: Promising early results. Health Policy. 2021; 125(5): 587–592.
- Zarządzenie nr 133/2023/DSOZ prezesa Narodowego Funduszu Zdrowia z dnia 11 września 2023 r. zmieniające zarządzenie w sprawie warunków zawierania i realizacji umów w rodzaju leczenie szpitalne – świadczenia kompleksowe. [Directive No. 133/2023/DSOZ of the President of the National Health Fund dated September 11, 2023, amending the directive regarding the conditions for concluding and implementing agreements of the hospital treatment - comprehensive services type.]. https://baw.nfz.gov.pl/NFZ/document/1998/Zarzadzenie-133_2023_DSOZ.
- Narodowy Fundusz Zdrowia. Funkcjonowanie programu KOS-zawał. [Performance of the KOS-Zawał Program]. https://ezdrowie.gov.pl/17066.
- Jankowski P, Topór-Mądry R, Gąsior M, et al. Innovative Managed Care May Be Related to Improved Prognosis for Acute Myocardial Infarction Survivors. Circ Cardiovasc Qual Outcomes. 2021; 14(8): e007800.
- Ranganathan P, Aggarwal R, Pramesh CS. Common pitfalls in statistical analysis: Odds versus risk. Perspect Clin Res. 2015; 6(4): 222–224.
- Kolarczyk-Haczyk A, Konopko M, Mazur M, et al. Long-term outcomes of the Coordinated Care Program in Patients after Myocardial Infarction (KOS-MI). Kardiol Pol. 2023 [Epub ahead of print].
- Daskalopoulou SS, Doonan RJ, Delaney JA, et al. Different patterns of statin use in patients with acute myocardial infarction. Curr Vasc Pharmacol. 2014; 12(6): 885–892.
- Shau WY, Lai CL, Huang ST, et al. Statin adherence and persistence on secondary prevention of cardiovascular disease in Taiwan. Heart Asia. 2019; 11(2): e011176.
- De Vera MA, Bhole V, Burns LC, et al. Impact of statin adherence on cardiovascular disease and mortality outcomes: a systematic review. Br J Clin Pharmacol. 2014; 78(4): 684–698.
- Rea F, Biffi A, Ronco R, et al. Cardiovascular Outcomes and Mortality Associated With Discontinuing Statins in Older Patients Receiving Polypharmacy. JAMA Netw Open. 2021; 4(6): e2113186.
- Jankowski P, Kosior DA, Sowa P, et al. Secondary prevention of coronary artery disease in Poland. Results from the POLASPIRE survey. Cardiol J. 2020; 27(5): 533–540.
- Thalmann I, Preiss D, Schlackow I, et al. Population-wide cohort study of statin use for the secondary cardiovascular disease prevention in Scotland in 2009-2017. Heart. 2023; 109(5): 388–395.
- Chen ST, Huang ST, Shau WY, et al. Long-term statin adherence in patients after hospital discharge for new onset of atherosclerotic cardiovascular disease: a population-based study of real world prescriptions in Taiwan. BMC Cardiovasc Disord. 2019; 19(1): 62.
- Ofori-Asenso R, Jakhu A, Zomer E, et al. Adherence and Persistence Among Statin Users Aged 65 Years and Over: A Systematic Review and Meta-analysis. J Gerontol A Biol Sci Med Sci. 2018; 73(6): 813–819.
